Glyn Edwards

Glyn Edwards has a comprehensive work experience spanning several companies and roles. Glyn is currently serving as the Executive Chairman at VacV Biotherapeutics and Chairman at MitoRx Therapeutics. Glyn has held various executive positions in the past, including CEO at Summit Therapeutics plc, Antisoma, and Oxford Cancer Biomarkers Ltd. Additionally, they have served as a Non-Executive Director at companies such as ORTHOSON Ltd and OxSonics Therapeutics. Glyn also has experience in business development as the VP of Business Development at Therapeutic Antibodies Inc. Glyn began their career at Celltech in an unspecified role. Notably, they also served as the Interim CEO at the BioIndustry Association, where they successfully restructured the organization to align costs with revenues and explored strategic options with other trade bodies.

Glyn Edwards obtained their BSc in Biochemistry from the University of Bristol, from 1973 to 1976. Glyn later pursued their MBA at the London Business School, completing it from 1983 to 1985.